|Mr. Thomas J. Shaw||Founder, Chairman, Pres & CEO||495.75k||N/A||1951|
|Ms. Michele M. Larios||VP, Gen. Counsel & Sec.||355.3k||N/A||1966|
|Mr. Russell B. Kuhlman||VP of Sales Devel.||156.26k||N/A||1954|
|Ms. Kathryn M. Duesman||Exec. Director of Global Health||187.97k||N/A||1963|
|Mr. John W. Fort III||Director, VP, CFO, Principal Accounting Officer & Treasurer||N/A||N/A||1969|
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States and internationally. It principally offers VanishPoint safety products comprising tuberculin, insulin, autodisable, and allergy antigen syringes; IV catheters; blood collection tube holders; blood collection sets; and Patient Safe safety medical products, including syringes and Luer caps. In addition, it engages in developing retractable needles and syringes, glass syringes, dental syringes, IV catheter introducers, and blood collection sets, as well as EasyPoint needles. Retractable Technologies, Inc. serves healthcare providers, such as acute care hospitals, alternate care facilities, doctors' offices, clinics, emergency centers, surgical centers, long-term care facilities, veterans administration facilities, military organizations, public health facilities, and prisons. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
Retractable Technologies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.